{"id":449378,"date":"2025-12-08T06:02:00","date_gmt":"2025-12-08T11:02:00","guid":{"rendered":"https:\/\/www.billingparadise.com\/blog\/?p=449378"},"modified":"2026-04-28T07:41:42","modified_gmt":"2026-04-28T12:41:42","slug":"strategies-for-orthopedic-groups-facing-reimbursement-cuts","status":"publish","type":"post","link":"https:\/\/www.billingparadise.com\/blog\/strategies-for-orthopedic-groups-facing-reimbursement-cuts\/","title":{"rendered":"Orthopedic Leaders Advice on Overcoming Fee Schedule Cuts and Declining Reimbursements"},"content":{"rendered":"
[vc_empty_space]
<\/a><\/a><\/a><\/a><\/a>Share on your feed<\/a><\/div><\/div>\n<\/div><\/div>

Table of contents<\/b><\/h2>\n<\/div><\/div>

Orthopedic Leaders Advice on Overcoming Fee Schedule Cuts and Declining Reimbursements
\n<\/a><\/p>\n<\/div><\/div>

Why Are Orthopedic Reimbursements Declining?
\n<\/a><\/p>\n<\/div><\/div>

What Should Orthopedic Leaders Do First to Prepare for 2026?
\n<\/a><\/p>\n<\/div><\/div>

Can Orthopedic Groups Control Costs Without Compromising Care?
\n<\/a><\/p>\n<\/div><\/div>

How Should Orthopedic Groups Approach Payer Negotiations in 2026?<\/a><\/p>\n<\/div><\/div>

Is Fee-for-Service Still Viable Or Should Orthopedic Groups Move Beyond It?
\n<\/a><\/p>\n<\/div><\/div>

How Should Leadership Align Around Financial Resilience?<\/a><\/p>\n<\/div><\/div>

Orthopedic Financial Stability Depends on Action, Not Hope<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/section><\/div>

[vc_empty_space]

Orthopedic Leaders Advice on Overcoming Fee Schedule Cuts and Declining Reimbursements<\/h2>\n

The major question for every orthopedic group leader is: Can orthopedic groups still maintain strong margins and financial stability?<\/p>\n

Yes, but only through active adaptation. Fee schedule cuts, including the 2.83% Medicare conversion factor reduction in 2025 and the planned 2.5% efficiency adjustment for 2026, will not reverse on their own, and waiting for legislation won’t protect your margins. With reimbursement declining an average of 1.5% annually after inflation adjustment, while labor and supply costs have climbed 82% per full-time equivalent from 2013 to 2022, the financial pressure is intensifying.\u200b<\/p>\n

Orthopedic practices must now think strategically about revenue leakage (where an estimated 80% of denials are avoidable, with 30% never being reprocessed), payer management (as prior authorization requests now average 39 per physician per week), cost control, and new payment models that enable greater financial flexibility and reimbursement control.<\/p>\n

Declining reimbursements are not the result of one problem. As industry experts, such as <\/span>Allison Farmer, CEO of EmergeOrtho<\/span><\/a>, one of the largest orthopedic practices in the U.S., have recently stated, the orthopedic sector is at a crossroads. She warned that,<\/span><\/p>\n

\u201cIf reimbursements do not significantly increase, organizations may have to begin cutting access to services, which is not the goal for any practice.\u201d<\/span><\/em><\/p>\n<\/div><\/div>[vc_empty_space]<\/div><\/div><\/section>

Why Are Orthopedic Reimbursements Declining?<\/h2>\n

Let\u2019s start with the biggest driver, the Medicare Physician Fee Schedule (MPFS) cuts. According to the American Association of Orthopaedic Surgeons (AAOS) comment letter on the 2026 Medicare Physician Fee Schedule, the conversion factor for CY 2025 included a <\/span>-2.83 % cut<\/span><\/a>, marking the fifth straight year of cuts.\u00a0 Due to the budget neutrality rule, gains in certain services must be offset by cuts in others, and procedural specialties tend to be on the losing side. This means that even as patient volumes rise with an aging Medicare population, payments per service are falling.<\/span><\/p>\n

At the same time, operational costs have surged; labor, implants, technology investments, rent, cybersecurity requirements, and compliance demands are all rising faster than payer reimbursement rates. Yet orthopedic groups cannot simply charge more because CMS and private payer contracts lock pricing in place.<\/span><\/p>\n

The pressure is worse in Medicare Advantage (MA) and commercial plans, which often pay below traditional Medicare rates and require more prior authorizations. MA plans introduce payment delays, administrative friction, and increasing denial risk, eroding the cash flow stability that orthopedic groups depend on.<\/span><\/p>\n

This multifactor challenge results in revenue per case trending downward, cost per case going upward, and a widening gap that threatens financial sustainability unless actions are taken now.<\/p>\n<\/div><\/div>

What Should Orthopedic Leaders Do First to Prepare for 2026?<\/h2>\n

The fastest way to respond to reimbursement decline is to understand where the margin pressure is happening. CFOs and COOs should immediately evaluate three things:<\/p>\n

    \n
  1. Which codes took the biggest hit under the 2025 fee schedule?<\/li>\n
  2. Which payers are causing the most denials, delays, or underpayments?<\/span><\/li>\n
  3. Which service lines have a negative contribution margin when fully costed?<\/span><\/li>\n<\/ol>\n

    Running a reimbursement audit is essential. By reviewing RVUs, conversion factors, payer mix, and case-level profitability, leadership can pinpoint where the practice is losing dollars, sometimes for years without realizing it. Groups that benchmark implant cost per case and OR utilization also tend to outperform peers financially because they catch hidden leakage early.<\/span><\/p>\n

    Once the true gaps are visible, the practice can start to act strategically rather than reactively.<\/span><\/p>\n<\/div><\/div>

    Can Orthopedic Groups Control Costs Without Compromising Care?<\/h2>\n

    Absolutely, and this is where operational efficiency becomes a competitive advantage. Many practices find substantial savings through:<\/p>\n